SK27699A3 - (s)-7-[(4,4'-bipiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-4- -methyl-3-oxo-1h-1,4-benzodiazepine-2-acetic acid, hydrochloride, processes for its preparation and methods for its use. - Google Patents

(s)-7-[(4,4'-bipiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-4- -methyl-3-oxo-1h-1,4-benzodiazepine-2-acetic acid, hydrochloride, processes for its preparation and methods for its use. Download PDF

Info

Publication number
SK27699A3
SK27699A3 SK276-99A SK27699A SK27699A3 SK 27699 A3 SK27699 A3 SK 27699A3 SK 27699 A SK27699 A SK 27699A SK 27699 A3 SK27699 A3 SK 27699A3
Authority
SK
Slovakia
Prior art keywords
benzodiazepine
bipiperidin
oxo
methyl
tetrahydro
Prior art date
Application number
SK276-99A
Other languages
English (en)
Slovak (sk)
Inventor
Stephen T Ross
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of SK27699A3 publication Critical patent/SK27699A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK276-99A 1996-09-03 1997-08-29 (s)-7-[(4,4'-bipiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-4- -methyl-3-oxo-1h-1,4-benzodiazepine-2-acetic acid, hydrochloride, processes for its preparation and methods for its use. SK27699A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03
PCT/US1997/015292 WO1998009629A1 (en) 1996-09-03 1997-08-29 Crystalline pharmaceutical product

Publications (1)

Publication Number Publication Date
SK27699A3 true SK27699A3 (en) 2000-02-14

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
SK276-99A SK27699A3 (en) 1996-09-03 1997-08-29 (s)-7-[(4,4'-bipiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-4- -methyl-3-oxo-1h-1,4-benzodiazepine-2-acetic acid, hydrochloride, processes for its preparation and methods for its use.

Country Status (32)

Country Link
US (1) US6335330B1 (ru)
EP (1) EP0964684B1 (ru)
JP (1) JP2000517342A (ru)
CN (1) CN1102391C (ru)
AP (1) AP9901472A0 (ru)
AR (1) AR008154A1 (ru)
AT (1) ATE245984T1 (ru)
AU (1) AU731173B2 (ru)
BG (1) BG103196A (ru)
BR (1) BR9711981A (ru)
CA (1) CA2264607A1 (ru)
CO (1) CO4930262A1 (ru)
CZ (1) CZ71999A3 (ru)
DE (1) DE69723873T2 (ru)
DZ (1) DZ2302A1 (ru)
EA (1) EA001363B1 (ru)
ES (1) ES2205254T3 (ru)
HU (1) HUP9904077A3 (ru)
ID (1) ID18156A (ru)
IL (1) IL128782A0 (ru)
MA (1) MA24309A1 (ru)
MY (1) MY118175A (ru)
NO (1) NO991013D0 (ru)
NZ (1) NZ334438A (ru)
OA (1) OA10986A (ru)
PE (1) PE107198A1 (ru)
PL (1) PL332006A1 (ru)
SK (1) SK27699A3 (ru)
TR (1) TR199900480T2 (ru)
UY (1) UY24690A1 (ru)
WO (1) WO1998009629A1 (ru)
ZA (1) ZA977870B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
WO2003059251A2 (en) 2001-10-22 2003-07-24 The Scripps Research Institute Antibody targeting compounds
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
WO2010093706A2 (en) 2009-02-10 2010-08-19 The Scripps Research Institute Chemically programmed vaccination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
ZA924760B (en) 1991-06-28 1993-03-31 Smithkline Beecham Corp Bicyclic fibrinogen antagonists
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
CN1041921C (zh) 1992-12-21 1999-02-03 史密丝克莱恩比彻姆公司 双环血纤维蛋白原拮抗剂
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
HUP9904077A2 (hu) 2000-05-28
EA199900260A1 (ru) 1999-08-26
EA001363B1 (ru) 2001-02-26
ATE245984T1 (de) 2003-08-15
MA24309A1 (fr) 1998-04-01
PL332006A1 (en) 1999-08-16
PE107198A1 (es) 1999-03-21
ID18156A (id) 1998-03-05
NO991013L (no) 1999-03-02
ES2205254T3 (es) 2004-05-01
NO991013D0 (no) 1999-03-02
US6335330B1 (en) 2002-01-01
DE69723873D1 (de) 2003-09-04
AU4242597A (en) 1998-03-26
EP0964684A4 (en) 2002-05-29
IL128782A0 (en) 2000-01-31
AU731173B2 (en) 2001-03-22
EP0964684B1 (en) 2003-07-30
BG103196A (en) 1999-09-30
TR199900480T2 (xx) 1999-06-21
OA10986A (en) 2003-03-04
DZ2302A1 (fr) 2002-12-28
EP0964684A1 (en) 1999-12-22
NZ334438A (en) 2000-10-27
BR9711981A (pt) 1999-08-24
HUP9904077A3 (en) 2002-03-28
CN1234739A (zh) 1999-11-10
CN1102391C (zh) 2003-03-05
CA2264607A1 (en) 1998-03-12
MY118175A (en) 2004-09-30
WO1998009629A1 (en) 1998-03-12
AR008154A1 (es) 1999-12-09
JP2000517342A (ja) 2000-12-26
DE69723873T2 (de) 2004-04-22
UY24690A1 (es) 1998-02-27
ZA977870B (en) 1998-03-03
AP9901472A0 (en) 1999-03-31
CZ71999A3 (cs) 1999-08-11
CO4930262A1 (es) 2000-06-27

Similar Documents

Publication Publication Date Title
KR960003615B1 (ko) 메틸 α-5(4,5,6,7-테트라하이드로(3,2-C)티에노 피리딜)(2-클로로페닐)-아세테이트의 우선성 광학이성체, 그 제법 및 그의 약제학적 조성물
JP2019135258A (ja) 第Ｘａ因子阻害剤の結晶形態
US20020004518A1 (en) Method of treating disorders related to protease-activated receptors-induced cell activation
HUT74103A (en) Aroyl-piperidine derivative
AU2982701A (en) Diazepan derivatives or salts thereof
JP5575979B2 (ja) シアノ基を含有するチエノピリジンエステル誘導体、その調製方法、使用および組成物
CA2515102A1 (en) Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
EP0964684B1 (en) Crystalline pharmaceutical product
RU2328501C1 (ru) Кристаллический клопидогрель нафталинсульфонат или его гидрат, способ его получения и содержащая его фармацевтическая композиция
JP2003246735A (ja) ヒドロピリジン誘導体酸付加塩を含有する医薬
AU2016282124B2 (en) Deuterated thienopiperidine derivatives, manufacturing method, and application thereof
EP3873446A1 (en) Therapeutic compounds and compositions
JPH0597674A (ja) コラーゲナーゼ阻害剤
MXPA99002118A (en) Crystalline pharmaceutical product
KR20000068406A (ko) 결정질 제약 물질
JPH08505867A (ja) 炎症治療用の可溶性補体レセプター１（ｓｃｒ−１）とアミジノフェニルまたはアミジノナフチルエステルの組み合わせ
KR101293350B1 (ko) 호중구증다 억제제
CN112778371A (zh) 一种噻吩并吡啶衍生物及其制备方法和用途
JP3162587B2 (ja) 新規複素環誘導体及び血小板凝集阻害剤
CA2476446A1 (en) Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
JPS5843919A (ja) 抗血栓剤
JPH0753561A (ja) テトラヒドロチエノピリジン誘導体、その製造方法及び抗血球凝集剤
JPH08325229A (ja) 新規なω−グアニジノ−Ｌ−α−アミノ酸アミド誘導体
JPH05255290A (ja) 腫瘍壊死因子産生阻害剤
JPS62242621A (ja) 抗血小板凝集剤